top of page
%20(11_087%20x%207%20in).jpg)
NEW BOOK
LATEST NEWS
Eli Lilly Acquires Verve Therapeutics for $1.3 Billion to Advance Gene Editing for Heart Disease
Eli Lilly has announced it will acquire Verve Therapeutics for up to $1.3 billion . The deal will help Lilly develop gene-editing...
Jul 20
Capricor's Shares Drop After FDA Rejects Deramiocel Cell Therapy for Heart Disease in DMD
Capricor Therapeutics faced a significant setback on July 11, 2025, when the FDA rejected its cell therapy, Deramiocel , for treating...
Jul 16
FDA Rejects Ultragenyx's Gene Therapy for Rare Disease - Sanfilippo Syndrome
The FDA has declined to approve Ultragenyx Pharmaceutical's gene therapy, UX111, for treating Sanfilippo syndrome type A, a rare genetic...
Jul 16
GENE TECH TIMES
The Future Has Arrived
Enhance CAR T-Cell Therapy Efficacy and Reduce Toxicity by Using the Microbiome
Past research has long suggested the significant impact of the microbiome on the efficacy of various anticancer treatments, including...
Feb 24
bottom of page